医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Dr. Reddy’s Appoints Dr. Sripada Chandrasekhar as President and Global Head of Human Resources

2013年08月13日 AM12:55
このエントリーをはてなブックマークに追加


 

HYDERABAD, India

Dr. Reddy’s has announced the appointment of Dr. Sripada Chandrasekhar as the President and Global Head of Human Resources; he will also be a member of Dr. Reddy’s Management Council. With over 30 years of experience, Dr. Chandrasekhar brings a rare blend of experience across India’s leading firms in Public, Private and Multi-National sectors – both in the early economy areas of steel and manufacturing as well as in the more recent domains of Telecom, IT Services and Consulting.

Prior to joining Dr. Reddy’s, Dr. Chandrasekhar worked with IBM in India as Vice President and Head of Human Resources for the India/South Asia region. He was a key member of their India Leadership Team and a Director on the Board of IBM India.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets. For more information, log on to:

www.drreddys.com

CONTACT

Dr. Reddy’s Laboratories Ltd.
Investors
and Financial Analysts:

Kedar Upadhye, +91-40-66834297
kedaru@drreddys.com
or
Saunak
Savla, +91-40-49002135
saunaks@drreddys.com
or
Milan
Kalawadia (USA), +1 908-203-4931
mkalawadia@drreddys.com
or
Media:
S
Rajan, +91-40-49002445
rajans@drreddys.com

同じカテゴリーの記事 

  • Makana™ Issued Patent in South Korea for Its Genetically-Modified TKO Pig for Use in Xenotransplantation
  • Fast Fitness Japan Obtains Master Franchisee Rights for Anytime Fitness in Germany
  • ATLATL Scientific and Miltenyi Biotec: A Five-Year Partnership Driving Biotech Innovation in Singapore and Beyond
  • 世界経済フォーラム(WEF)特別会合リヤドが閉幕平和と繁栄への明確で不可逆的な道をグローバルな最優先課題とすることを呼びかける
  • 世界经济论坛特别会议闭幕,全球领导人呼吁:探寻通往和平与繁荣的清晰、不可逆转路径应为全球首要任务